About
Technology
Product
Partners
- Strategic Partnerships
- Teva
Clinical Trials
News & Events
- News
- Events
Investors
Careers

pp_2014_graphic_600

Category:

Product Pipeline

Ambit is currently in product development of the following:

» Quizartinib (FLT3)
» AC410 (JAK2)
» CSF1R Program
» CSF1R Program
» CEP32496 (BRAF)

Your Kinase Partner of Choice

From profiling services to clinical development expertise, find out what Ambit has to offer.

Privacy Policy
Terms of Use
Contact Us

© 2024 www.ambitbio.com. All rights reserved.